Trials / Completed
CompletedNCT00090181
Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)
A Double-Blind, Parallel-group, 4-Week Trial to Assess the Efficacy and Safety of Etoricoxib 60 mg and Diclofenac 150 mg in Patients With Chronic Low Back Pain
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 401 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of MK0663 for the treatment of chronic low back pain and to investigate the overall safety and tolerability over four weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0663, etoricoxib / Duration of Treatment: 4 weeks | |
| DRUG | Comparator: diclofenac / Duration of Treatment: 4 weeks |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2005-03-01
- Completion
- 2005-03-01
- First posted
- 2004-08-27
- Last updated
- 2022-02-15
Source: ClinicalTrials.gov record NCT00090181. Inclusion in this directory is not an endorsement.